Extracellular engagement of α6 integrin inhibited urokinase-type plasminogen activator-mediated cleavage and delayed human prostate bone metastasis

Cancer Research

Volumn 69, Issue 12, 2009, Pages 5007-5014

  Ports, Michael O ^a   Nagle, Ray B ^a,b   Pond, Gerald D ^a   Cress, Anne E ^a,c  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA6 INTEGRIN; MONOCLONAL ANTIBODY; UROKINASE; PRIMER DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE METASTASIS; CANCER INVASION; CELL INVASION; CELL SURFACE; CONTROLLED STUDY; ENZYME INHIBITION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; SCID MOUSE; ANIMAL; BONE TUMOR; DRUG ANTAGONISM; ENZYMOLOGY; FLOW CYTOMETRY; HYDROLYSIS; IMMUNOHISTOCHEMISTRY; METABOLISM; METASTASIS; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ANIMALS; BASE SEQUENCE; BONE NEOPLASMS; CELL LINE, TUMOR; DNA PRIMERS; FLOW CYTOMETRY; HUMANS; HYDROLYSIS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA6; MALE; MICE; MICE, SCID; PROSTATIC NEOPLASMS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 67449123333     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-0354     Document Type: Article

References (54)

1. 1) integrin involved in migration but not adhesion is required for extravasation of murine melanoma B16F1 cells in liver. Cancer Res 1997;57:3812-3817
2. 6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res 1995;55:901-906
3. 4 integrin expression in breast carcinomas is affected by laminin production from tumor cells. Clin Cancer Res 1998;4:407-410
4. Danen EH, van Muijen GN, van de Wiel-van Kemenade E, Jansen KF, Ruiter DJ, Figdor CG. Regulation of integrin-mediated adhesion to laminin and collagen in human melanocytes and in non-metastatic and highly metastatic human melanoma cells. Int J Cancer 1993;54:315-321 (Pubitemid 23154900)
5. van der Flier A, Sonnenberg A. Function and interactions of integrins. Cell Tissue Res 2001;305:285-298
6. Ayala GE, Dai H, Powell M, et al. Cancer-related axonogenesis and neurogenesis in prostate cancer. Clin Cancer Res 2008;14:7593-7603
7. Villers A, McNeal JE, Redwine EA, Freiha FS, Stamey TA. The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J Urol 1989;142:763-768 (Pubitemid 19226718)
8. Jacobs SC. Spread of prostatic cancer to bone. Urology 1983;21:337-344 (Pubitemid 13161851)
9. Singh G, Orr FW. Bone metastasis and molecular mechanisms: pathophysiology. Dordrecht: Kluwer Academic; 2004; xvi, 308.
10. Siler U, Seiffert M, Puch S, et al. Characterization and functional analysis of laminin isoforms in human bone marrow. Blood 2000;96:4194-4203
11. 5-containing laminins as adhesive proteins for multipotent hematopoietic FDCP-Mix cells. Blood 1999;93:2533-2542
12. Gu YC, Kortesmaa J, Tryggvason K, et al. Laminin isoform-specific promotion of adhesion and migration of human bone marrow progenitor cells. Blood 2003;101:877-885 (Pubitemid 36139354)
13. Fornaro M, Manes T, Languino LR. Integrins and prostate cancer metastases. Cancer Metastasis Rev 2001;20:321-331
14. 4 integrins in human prostate cancer progression. Cancer Metastasis Rev 1995;14:219-228
15. Nagle RB, Hao J, Knox JD, Dalkin BL, Clark V, Cress AE. Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue. Am J Pathol 1995;146:1498-1507
16. 2) by human malignant and normal prostate. Am J Pathol 1996;149:1341-1349
17. Demetriou MC, Cress AE. Integrin clipping: a novel adhesion switch? J Cell Biochem 2004;91:26-35.
18. 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer. Exp Cell Res 2004;294:550-558
19. Sheng S. The urokinase-type plasminogen activator system in prostate cancer metastasis. Cancer Metastasis Rev 2001;20:287-296 (Pubitemid 34595272)
20. Shariat SF, Roehrborn CG, McConnell JD, et al. Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis. J Clin Oncol 2007;25:349-355 (Pubitemid 350002982)
21. 6 cleavage: a novel modification to modulate cell migration. Exp Cell Res 2007;313:1080-1089
22. Ginsberg MH, Partridge A, Shattil SJ. Integrin regulation. Curr Opin Cell Biol 2005;17:509-516 (Pubitemid 41267165)
23. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002;110:673-687 (Pubitemid 35283958)
24. 1 chain. FEBS Lett 1997;416:212-216
25. 6 subunit for the binding of autoantibody and its role in basement membrane separation in oral pemphigoid. J Immunol 2006;176:1968-1977.
26. Mignogna M, Lanza A, Rossiello L, Ruocco V, Ahmed AR. Comparison of reactivity and epitope recognition between sera from American and Italian patients with oral pemphigoid. Clin Exp Immunol 2006;145:28-35. (Pubitemid 43893929)
27. 1 laminin receptor. J Biol Chem 1993;268:18427-18430
28. 6 integrin in prostate cancer migration and bone pain in a novel xenograft model. PLoS ONE 2008;3:3535.
29. Damsky CH, Librach C, Lim KH, et al. Integrin switching regulates normal trophoblast invasion. Development 1994;120:3657-3666 (Pubitemid 24367008)
30. Tran NL, Nagle RB, Cress AE, Heimark RL. N-cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion with stromal cells. Am J Pathol 1999;155:787-798 (Pubitemid 29426824)
31. van Bokhoven A, Varella-Garcia M, Korch C, Hessels D, Miller GJ. Widely used prostate carcinoma cell lines share common origins. Prostate 2001;47:36-51. (Pubitemid 32246751)
32. Arguello F, Baggs RB, Frantz CN. A murine model of experimental metastasis to bone and bone marrow. Cancer Res 1988;48:6876-6881 (Pubitemid 19012221)
33. Arguello F, Furlanetto RW, Baggs RB, et al. Incidence and distribution of experimental metastases in mutant mice with defective organ microenvironments (genotypes Sl/Sld and W/Wv). Cancer Res 1992;52:2304-2309
34. Ohara O, Temple G. Directional cDNA library construction assisted by the in vitro recombination reaction. Nucleic Acids Res 2001;29:22.
35. Lee SB, Hong SK, Choe G, Lee SE. Periprostatic distribution of nerves in specimens from non-nerve-sparing radical retropubic prostatectomy. Urology 2008;72:878-881
36. 4 subunit. J Cell Sci 1994;107:543-552
37. 4 protein complexes: tissue distribution and biochemical properties. J Cell Sci 1990;96:207-217
38. 1 Integrin activates Rac1 in Schwann cells to generate radial lamellae during axonal sorting and myelination. J Cell Biol 2007;177:1063-1075
39. Coman DR, deLong RP, McCutcheon M. Studies on the mechanisms of metastasis; the distribution of tumors in various organs in relation to the distribution of arterial emboli. Cancer Res 1951;11:648-651
40. 6 integrin. J Biol Chem 2001;276:26099-26106
41. Harms JF, Welch DR. MDA-MB-435 human breast carcinoma metastasis to bone. Clin Exp Metastasis 2003;20:327-334 (Pubitemid 36745661)
42. Phadke PA, Mercer RR, Harms JF, et al. Kinetics of metastatic breast cancer cell trafficking in bone. Clin Cancer Res 2006;12:1431-1440
43. Wetterwald A, van der Pluijm G, Que I, et al. Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease. Am J Pathol 2002;160:1143-1153 (Pubitemid 34224600)
44. 6 Integrin cleavage: sensitizing human prostate cancer to ionizing radiation. Int J Radiat Biol 2007;83:761-767
45. Kaufmann R, Hainzl A, Sterry W, Alberti S, Klein CE. In vivo targeting of integrin receptors in human skin xenografts by intravenously applied antibodies. Arch Dermatol Res 1994;286:6-11.
46. 4 in homing of fetal liver hematopoietic stem and progenitor cells. Blood 2007;110:2399-2407
47. Wikman H, Vessella R, Pantel K. Cancer micrometastasis and tumour dormancy. APMIS 2008;116:754-770
48. Allan AL, Vantyghem SA, Tuck AB, Chambers AF. Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis. Breast Dis 2006;26:87-98. (Pubitemid 46655481)
49. Kaijzel EL, Snoeks TJ, Buijs JT, van der Pluijm G, Lowik CW. Multimodal imaging and treatment of bone metastasis. Clin Exp Metastasis 2009;26:371-379
50. Dondi D, Festuccia C, Piccolella M, Bologna M, Motta M. GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system. Oncol Rep 2006;15:393-400.
51. Hemler ME. Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 2005;6:801-811 (Pubitemid 41726118)
52. Berditchevski F. Complexes of tetraspanins with integrins: more than meets the eye. J Cell Sci 2001;114:4143-4151 (Pubitemid 33138652)
53. Kugler MC, Wei Y, Chapman HA. Urokinase receptor and integrin interactions. Curr Pharm Des 2003;9:1565-1574 (Pubitemid 36758315)
54. Tarui T, Mazar AP, Cines DB, Takada Y. Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interaction. J Biol Chem 2001;276:3983-3990 (Pubitemid 33645864)